Phase II Clinical Trial of NKT Cell-Targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple SclerosisTomoko Okamoto,Wakiro Sato,Youwei Lin,Yukio Kimura,Noriko Sato,Yuko Shimizu,Yoichiro Nishida,Takanori Yokota,Masanori Taketsuna, Yu Okada,Takami Ishizuka,Harumasa Nakamura,Sachiko Miyake,Yuji Takahashi,Takashi YamamuraMULTIPLE SCLEROSIS JOURNAL(2023)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要